Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
HyperMabs is a biopharmaceutical company that designs and develops innovative therapeutics targeting lung diseases. HyperMabs is currently evaluating a drug candidate developed using in-silico methods to target lung disease. For this project, we aim to study the biodistribution of HyperMabs therapeutic, currently in its pre-clinical stage designed to treat several lung diseases. To achieve this, we wish to label the HyperMabs therapeutic with a labeling molecule to facilitate visualization of distribution of the therapeutic in lungs. The results obtained from this study will help the company to understand the efficacy of the drug which is crucial in optimising the dosing parameters to achieve maximum therapeutic benefits.
Elias Georges
Ashruti Jadvani
HyperMabs Inc
Other
Professional, scientific and technical services
McGill University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.